Concepts (119)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiography, Thoracic | 3 | 2014 | 1320 | 0.870 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 2 | 2021 | 936 | 0.790 |
Why?
|
| Tomography | 2 | 2014 | 442 | 0.770 |
Why?
|
| Radiographic Image Enhancement | 3 | 2015 | 877 | 0.750 |
Why?
|
| Ultrasonography, Mammary | 1 | 2021 | 241 | 0.640 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2021 | 395 | 0.520 |
Why?
|
| Image Enhancement | 2 | 2017 | 2894 | 0.470 |
Why?
|
| Contrast Media | 5 | 2019 | 5337 | 0.450 |
Why?
|
| Gadolinium DTPA | 1 | 2017 | 823 | 0.440 |
Why?
|
| Mammography | 4 | 2021 | 2434 | 0.440 |
Why?
|
| Thoracic Diseases | 1 | 2014 | 99 | 0.430 |
Why?
|
| Breast Neoplasms | 8 | 2021 | 21163 | 0.420 |
Why?
|
| Preoperative Care | 1 | 2021 | 2257 | 0.400 |
Why?
|
| Triiodobenzoic Acids | 1 | 2011 | 123 | 0.370 |
Why?
|
| Breast | 5 | 2021 | 1975 | 0.320 |
Why?
|
| Gadolinium | 1 | 2013 | 965 | 0.300 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2021 | 36849 | 0.280 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2013 | 1092 | 0.260 |
Why?
|
| Lung Diseases | 2 | 2014 | 1925 | 0.260 |
Why?
|
| Sarcoma | 1 | 2017 | 1806 | 0.250 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2022 | 9063 | 0.230 |
Why?
|
| Myocardial Ischemia | 1 | 2013 | 2139 | 0.210 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2015 | 20766 | 0.200 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 11254 | 0.190 |
Why?
|
| Injections, Intravenous | 2 | 2014 | 1378 | 0.180 |
Why?
|
| Kidney Diseases | 1 | 2011 | 2103 | 0.170 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2017 | 9433 | 0.150 |
Why?
|
| Diagnosis, Differential | 4 | 2021 | 13019 | 0.130 |
Why?
|
| Arm Bones | 1 | 2015 | 4 | 0.130 |
Why?
|
| Kidney | 1 | 2011 | 7063 | 0.130 |
Why?
|
| Excipients | 1 | 2014 | 98 | 0.120 |
Why?
|
| Immune Reconstitution Inflammatory Syndrome | 1 | 2014 | 61 | 0.110 |
Why?
|
| Lung | 1 | 2013 | 10087 | 0.110 |
Why?
|
| Reproducibility of Results | 2 | 2021 | 20224 | 0.100 |
Why?
|
| Herpesviridae Infections | 1 | 2014 | 269 | 0.100 |
Why?
|
| Wrist Injuries | 1 | 2015 | 215 | 0.100 |
Why?
|
| Foreign-Body Migration | 1 | 2014 | 220 | 0.100 |
Why?
|
| ROC Curve | 2 | 2019 | 3622 | 0.100 |
Why?
|
| Herpesvirus 8, Human | 1 | 2014 | 256 | 0.100 |
Why?
|
| Fracture Healing | 1 | 2015 | 448 | 0.100 |
Why?
|
| Postoperative Period | 1 | 2017 | 1830 | 0.100 |
Why?
|
| Pneumonia, Bacterial | 1 | 2014 | 319 | 0.090 |
Why?
|
| Injections, Intra-Arterial | 1 | 2011 | 181 | 0.090 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2014 | 530 | 0.080 |
Why?
|
| Lung Injury | 1 | 2014 | 433 | 0.080 |
Why?
|
| Aged | 7 | 2021 | 171544 | 0.080 |
Why?
|
| Workplace | 1 | 2015 | 872 | 0.080 |
Why?
|
| Radiology | 2 | 2020 | 2117 | 0.080 |
Why?
|
| Middle Aged | 8 | 2021 | 223463 | 0.080 |
Why?
|
| Sensitivity and Specificity | 2 | 2021 | 14736 | 0.070 |
Why?
|
| Humans | 19 | 2021 | 768298 | 0.070 |
Why?
|
| HIV Infections | 1 | 2014 | 17575 | 0.070 |
Why?
|
| Retrospective Studies | 6 | 2021 | 81768 | 0.070 |
Why?
|
| Polyethyleneimine | 1 | 2007 | 68 | 0.070 |
Why?
|
| Female | 12 | 2021 | 397050 | 0.060 |
Why?
|
| Prospective Studies | 3 | 2021 | 54921 | 0.060 |
Why?
|
| Equipment Design | 1 | 2014 | 3529 | 0.060 |
Why?
|
| Health Surveys | 1 | 2015 | 4056 | 0.060 |
Why?
|
| Creatinine | 1 | 2011 | 1915 | 0.060 |
Why?
|
| Adult | 8 | 2021 | 223622 | 0.060 |
Why?
|
| Serum Albumin, Bovine | 1 | 2006 | 320 | 0.060 |
Why?
|
| Anti-Retroviral Agents | 1 | 2014 | 1794 | 0.060 |
Why?
|
| Chitosan | 1 | 2006 | 140 | 0.060 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2016 | 2820 | 0.060 |
Why?
|
| Health Behavior | 1 | 2015 | 2647 | 0.060 |
Why?
|
| Fractures, Bone | 1 | 2015 | 2062 | 0.050 |
Why?
|
| Gene Transfer Techniques | 1 | 2007 | 1209 | 0.050 |
Why?
|
| Plasmids | 1 | 2007 | 2267 | 0.050 |
Why?
|
| Delayed-Action Preparations | 1 | 2006 | 968 | 0.050 |
Why?
|
| Regression Analysis | 1 | 2011 | 6350 | 0.050 |
Why?
|
| Drug Carriers | 1 | 2006 | 710 | 0.050 |
Why?
|
| Lactic Acid | 1 | 2006 | 1140 | 0.040 |
Why?
|
| Internship and Residency | 1 | 2020 | 5948 | 0.040 |
Why?
|
| Spectrum Analysis | 1 | 2021 | 449 | 0.040 |
Why?
|
| Age Factors | 2 | 2018 | 18472 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 59683 | 0.040 |
Why?
|
| Exercise | 1 | 2015 | 5947 | 0.040 |
Why?
|
| Nanoparticles | 2 | 2007 | 1986 | 0.040 |
Why?
|
| Accreditation | 1 | 2020 | 478 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2013 | 10464 | 0.030 |
Why?
|
| DNA | 1 | 2007 | 7211 | 0.030 |
Why?
|
| Kinetics | 1 | 2019 | 6334 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2018 | 15455 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2007 | 9618 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2014 | 13576 | 0.020 |
Why?
|
| Male | 4 | 2017 | 364870 | 0.020 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2015 | 1226 | 0.020 |
Why?
|
| Education, Medical, Graduate | 1 | 2020 | 2411 | 0.020 |
Why?
|
| Disability Evaluation | 1 | 2015 | 1838 | 0.020 |
Why?
|
| Neurons | 1 | 2007 | 9512 | 0.020 |
Why?
|
| Neurotensin | 1 | 2007 | 60 | 0.020 |
Why?
|
| PC12 Cells | 1 | 2007 | 317 | 0.020 |
Why?
|
| Mixed Function Oxygenases | 1 | 2007 | 265 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2007 | 669 | 0.020 |
Why?
|
| Mass Screening | 1 | 2021 | 5451 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2015 | 3579 | 0.010 |
Why?
|
| Ganglia, Spinal | 1 | 2007 | 530 | 0.010 |
Why?
|
| Diffusion | 1 | 2006 | 818 | 0.010 |
Why?
|
| Radiography | 1 | 2014 | 6993 | 0.010 |
Why?
|
| Materials Testing | 1 | 2006 | 872 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2007 | 2068 | 0.010 |
Why?
|
| Particle Size | 1 | 2006 | 1653 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2007 | 1674 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8750 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2016 | 4847 | 0.010 |
Why?
|
| Astrocytes | 1 | 2007 | 1349 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2016 | 22292 | 0.010 |
Why?
|
| Pharmaceutical Preparations | 1 | 2006 | 1088 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2018 | 24316 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2007 | 4175 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2007 | 5898 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2007 | 4526 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2007 | 5151 | 0.010 |
Why?
|
| Rats | 1 | 2007 | 23833 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2007 | 11659 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2007 | 22355 | 0.000 |
Why?
|
| Pregnancy | 1 | 2007 | 30198 | 0.000 |
Why?
|
| Mice | 1 | 2007 | 82004 | 0.000 |
Why?
|
| Animals | 1 | 2007 | 169322 | 0.000 |
Why?
|
Concepts
(119)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(13)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_